Skip to main content

Month: July 2022

DISCLOSURE OF LARGE SHAREHOLDING – AQUA-SPARK

Reference is made to the stock exchange announcement by Hofseth BioCare ASA (the “Company“) on 3 July 2022 regarding completion of a private placement of new shares (the “Private Placement“). In the Private Placement, the Company will issue a total of 35,490,000 new shares. Aqua-Spark Coöperatieve U.A. applied for and was allocated 10,350,000 shares in the Private Placement at a price per share of NOK 4.  After the issuance of the new shares in the Private Placement, the shareholding of Aqua-Spark will be more than 5% of the Company’s share capital. Following the Private Placement, Aqua-Spark will hold 22,450,000 shares in the Company, corresponding to 5.71% of the shares and votes outstanding after completion of the Private Placement. This information is subject to the disclosure requirements pursuant to...

Continue reading

Hofseth Biocare ASA: NOTIFIABLE TRANSACTIONS IN CONNECTION WITH PRIVATE PLACEMENT

Reference is made to the stock exchange notice from Hofseth BioCare ASA (“HBC” or the “Company”) published on 3 July 2022 regarding the completion of a private placement raising gross proceeds of approximately NOK 141 million (the “Private Placement”) through issuance of new shares (the “Offer Shares”) in the Company with a subscription price of NOK 4 per Offer Share (the “Offer Price”). The following persons discharging managerial responsibilities and their close associates have been allocated Offer Shares the Private Placement at the Offer Price: i) RH Industri AS, a close associate of CEO Roger Hofseth, has been allocated 17,800,190 Offer Shares, for a total subscription amount of NOK 71,200,760; andii) In order to facilitate for partial settlement on a delivery versus payment...

Continue reading

ALK spotlights the impact of respiratory allergies on children at EAACI Congress

Four leading experts in respiratory allergy spotlight the impact of respiratory allergy in children, in an ALK-sponsored symposium at the EAACI Congress The growing availability of evidence-based allergy immunotherapy treatments for paediatric patients offers increased treatment options for prescribers ALK has enrolled more than 3,000 paediatric patients in eight Phase III clinical trials of its SLIT-tablets, as it pursues indications for children and adolescents around the worldALK has thrown a spotlight onto paediatric respiratory allergy and the major treatment advances seen in recent years at a company-sponsored symposium at the Annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI), in Prague, Czechia this week. In a session presented by four of the world’s leading experts in respiratory allergy, EAACI...

Continue reading

After 25 Years of Delivering Value to Mali, Barrick Continues to Invest in the Future

All amounts expressed in US Dollars LOULO GOLD MINE, Mali, July 02, 2022 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD) (TSX:ABX) continues to invest in creating value for all stakeholders and in supporting the communities that host its mines, president and chief executive Mark Bristow said here today. Speaking to media at the company’s Loulo-Gounkoto complex, Bristow noted the commissioning of the Gounkoto underground mine and the Gara West open pit, the continuing replacement of reserves, the extension of the solar power plant and the further strengthening of local partnerships as instances of the company’s long-term commitment to the country. “In the first half of the year we’ve contributed $337 million to the Malian economy in the form of taxes, royalties, dividends, salaries and payments to local suppliers, taking...

Continue reading

CORRECTION — The New America High Income Fund, Inc.

BOSTON, July 01, 2022 (GLOBE NEWSWIRE) — In a release issued on Thursday, June 30th by The New America High Income Fund, Inc. (NYSE: HYB), please note that in the first paragraph of the release, the dates should be July 15, 2022 and July 14th, not June 15, 2022 and June 14th, as previously stated. The corrected release follows: The New America High Income Fund, Inc. Declares Dividend The New America High Income Fund, Inc. (the “Fund”) (NYSE: HYB) announced today that it will pay a dividend of $.05 per share on the company’s common stock on July 29, 2022 to common shareholders of record as of the close of business on July 15, 2022. The ex-dividend date will be July 14th. The Fund has released updated portfolio data which can be found on the Fund’s website at www.newamerica-hyb.com. The New America High Income Fund, Inc. is a diversified,...

Continue reading

An Update from Trump Media & Technology Group

SARASOTA, Fla., July 01, 2022 (GLOBE NEWSWIRE) — Trump Media & Technology Group (“TMTG”) today issued the following statement: “TMTG is expanding and enhancing Truth Social, with a major update to the platform scheduled for next week. TMTG will continue cooperating fully with inquiries into our planned merger and will comply with subpoenas we’ve recently received, none of which were directed at the company’s Chairman or CEO.” Investor Relations Contact:MZ Group – North Americatmtgir@mzgroup.us  Media Contact:press@tmtgcorp.com 

Continue reading

Kayne Anderson NextGen Energy & Infrastructure Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at June 30, 2022

HOUSTON, July 01, 2022 (GLOBE NEWSWIRE) — Kayne Anderson NextGen Energy & Infrastructure, Inc. (the “Fund”) (NYSE: KMF) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of June 30, 2022. As of June 30, 2022, the Fund’s net assets were $433.1 million and its net asset value per share was $9.18. As of June 30, 2022, the Fund’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 459% and the Fund’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 349%.     Kayne Anderson NextGen Energy & Infrastructure, Inc.Statement of Assets and LiabilitiesJune 30, 2022(Unaudited)    (in...

Continue reading

Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios at June 30, 2022

HOUSTON, July 01, 2022 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of June 30, 2022. As of June 30, 2022, the Company’s net assets were $1.3 billion, and its net asset value per share was $9.62. As of June 30, 2022, the Company’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 426% and the Company’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 351%. Kayne Anderson Energy Infrastructure Fund, Inc.Statement of Assets and LiabilitiesJune 30, 2022(Unaudited)    (in...

Continue reading

Aequus Provides General Update and Reports Record 2021 Financial Results

Also reports Financial Results for the 3 months ended March 31, 2022 VANCOUVER, British Columbia, July 01, 2022 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a sales force that currently markets third party or exclusively licensed products for which the Company receives revenues from direct product sales and profit share arrangements, today reported financial results for the year ended December 31, 2021 (“Fiscal 2021”) and the three months ended March 31, 2022 (“Q1 2022”), and reports associated Company developments. Unless otherwise noted, all figures are in Canadian currency. Mr. Janzen commented “Waiting for our auditors to complete their audit of the annual financial statement have been frustrating for both ourselves and our shareholders....

Continue reading

IHT FISCAL FIRST QUARTER REVENUE, PROFIT, AND EQUITY MAINTAIN UPWARD MOMENTUM

Phoenix, AZ, July 01, 2022 (GLOBE NEWSWIRE) — InnSuites Hospitality Trust (NYSE American: IHT) continued its strong rebound with 2023 First Fiscal Quarter (February 1, 2022, to April 30, 2022), revenues of approximately $2.136 million, up 53% from the prior Fiscal Year First Quarter. Total Consolidated Fiscal First Quarter Net Income increased 139% to $376,187. Earnings Per Share based on this First Fiscal Quarter Consolidated Net Income were $0.05 per share, up $0.03 from prior year income of $0.02, an all-time First Fiscal Quarter record. Total Trust Equity increased to $4,312,186 at the end of Fiscal First Quarter 2023, up 56%, or $1,551,898 million, from the $2,760,288 reported at the end of the prior Year Fiscal First Quarter. Net Income before non-cash depreciation expense was $359,806 for the Fiscal First Quarter ended April...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.